Prophylactic immunisation against traveller's diarrhoea caused by enterotoxin-forming strains of Escherichia coli and against cholera: does it make sense and for whom?

  • T Weinke
  • I Liebold
  • Gerd-Dieter Burchard
  • N Frühwein
  • M P Grobusch
  • C Hatz
  • H Kollaritsch
  • H D Nothdurft
  • E Reisinger
  • B Rieke
  • Ch Schönfeld
  • R Steffen
  • A Stich

Beteiligte Einrichtungen

Abstract

Traveller's diarrhoea (TD) constitutes the most common disease relevant to travel medicine with ETEC as the leading causative pathogen. Cholera is the most serious, but very rare form of TD. ETEC and cholera share pathogenic mechanisms by producing a toxin that has an 80% amino acid homology. A consensus of German-speaking experts sees the indication to use the whole cell/B subunit oral cholera vaccine (WC--BS) if cholera is a risk for aid workers or travellers with an anticipated threat of cholera who stay under poor hygienic conditions. The use of the vaccine should be considered in the indication to avoid ETEC TD for travellers with predisposing illness or medication or for travellers at risk to develop a serious course.

Bibliografische Daten

OriginalspracheDeutsch
Aufsatznummer6
ISSN1477-8939
StatusVeröffentlicht - 2008
pubmed 18984481